The Loma Linda University PGY2 Oncology Pharmacy Residency is fully accredited by the American Society of Health-System Pharmacists (ASHP). The PGY2 Oncology resident will develop the knowledge, attitude, and skills necessary to become an advanced pharmaceutical care practitioner in the area of oncology. The program is structured to suit the individual needs of the resident and provide an environment of quality training in pharmaceutical care. The PGY2 Oncology Residency Program offers the opportunity to experience a variety of oncology practice settings. Your unique residency can include learning experiences such as adult oncology, pediatric oncology, ambulatory infusion clinics, palliative care service, investigational drug service, or symptom management clinic. With a growing number of PGY2 programs, Loma Linda University is dedicated to the necessary training of competent clinical pharmacists in specialized areas. Loma Linda University Medical Center is home of the Loma Linda University Cancer Center and the James M. Slater Proton Treatment and Research Center, and is affiliated with the Loma Linda University School of Pharmacy.
Loma Linda University (LLU) is a Seventh-day Adventist educational health sciences institution with more than 4,000 students located in Southern California. Eight schools compromise the University organization, with more than 55 programs offered including Medicine, Pharmacy, Dentistry, Nursing, Public Health, and Religion.
The Pharmacy Residency programs at Loma Linda University are under a joint collaboration between Loma Linda University Medical Center and Loma Linda University School of Pharmacy.